Current Assets Cambiamento Data
Abbott USD 23.51B 872M 2023-06
ANI Pharmaceuticals USD 519.82M 22.6M 2023-12
Aurora Cannabis CAD 479.93M 62.86M 2023-03
Bristol-Myers Squibb USD 27.63B 442M 2023-09
Canopy Growth CAD 493.7M 389.53M 2023-09
Cara Therapeutics USD 100.6M 24.13M 2023-09
Corcept Therapeutics USD 458.64M 27.11M 2023-12
Eisai JPY 659.27B 19.2B 2023-09
Eli Lilly USD 23.01B 1.68B 2023-09
Marinus Pharmaceuticals USD 195.04M 431K 2023-09
Pacira USD 509.99M 62.74M 2023-12
Perrigo USD 2.77B 7.7M 2023-09
Pfizer USD 74.01B 665M 2023-09
Revance Therapeutics USD 388.52M 9.57M 2023-09
Supernus Pharmaceuticals USD 493.11M 43.75M 2023-12
United Therapeutics USD 3.55B 92.1M 2023-12
Xeris Pharmaceuticals USD 158.05M 2.31M 2023-09



Supernus Pharmaceuticals Attività Correnti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2024.